NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers Post Job | Search Resumes

NEWSLETTERS
Free Newsletters
Archive

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News

CAREER NETWORK
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

DIVERSITY

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

  News | News By Subject | News by Disease |  News By Date | Search News
 News By Date

SuMoTuWeThFrSa
272829303112
3456789
10111213141516
17181920212223
24252627282930
31123456
 Thursday, August 28, 2008
 Top Breaking News
Belgian Drugmaker UCB, Inc. (UCBJF.PK) to Cut 2,000 Jobs Worldwide     More...
Replidyne, Inc. (RDYN) to Restructure Ops, Cut 80% Jobs     More...
GlaxoSmithKline (GSK) (JOBS) Signs Deal Worth Up to $820 Million with Valeant Pharmaceuticals International (VRX)     More...
China Dermatology Startup, Profex Raises $15.5 Million     More...
The New England Journal of Medicine Publishes Millennium's Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients; Velcade Found Better Than Standard Drug     More...
Alkermes (ALKS) Slides on Diabetes Drug Concerns     More...
Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin; Primary Objective Met     More...
Zealand Pharma Appoints New Chief Executive Officer     More...
ThromboGenics Ltd. (THR.BR) Appoints Dr. Patrik De Haes as Chief Executive Officer     More...
Skyepharma PLC (SKYE) Shares Surge on Hopes for Bonds Deal     More...
FDA Grants IND for Pro-Pharmaceuticals, Inc. (PRW) DAVANAT(R) to Treat Breast Cancer Patient     More...
Schering-Plough Corporation (SGP) Wins OK From EU to Sell Animal Drugs to Pfizer Inc. (PFE)     More...
 Featured Stories
Boehringer Ingelheim GmbH Newer Blood Pressure Drug No Better Than Placebo in Preventing Stroke, McMaster University and University of Miami's Miller School of Medicine Study     More...
Study Outcome Won't Sway Genentech, Inc. (DNA) On Eye Drug     More...
Howard Hughes Medical Institute and Harvard Stem Cell Institute Researchers Create Insulin-Producing Cells from Adult Pancreatic Cells     More...
Early Trigger for Type-1 Diabetes Found in Mice, Stanford University Scientists Report     More...
National Institutes of Health (NIH) Study Points To Brain Chemical Involved In Obesity     More...
Elan Corporation PLC (ELN) Says Tysabri Brain Disease Link Uncertain     More...
Common Treatment to Delay Labor Decreases Preterm Infants' Risk for Cerebral Palsy, National Institutes of Health (NIH) Study     More...
Gene Therapy May Restore Hearing, Oregon Health & Science University (OHSU) Study     More...
Presidential Elections Will Force Stem Cell Showdown     More...
Olive Leaf Extract Can Help Tackle High Blood Pressure And Cholesterol     More...
China Botanic Buys Guangdong Kangli Pharma     More...
 More News
Meda AB (SE:MEDAa): Anticipated Approval Of Onsolis(TM) During First Half 2009 Following Receipt of Complete Response Letter from FDA     More...
Stallergenes, S.A. (GENP.PA) New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber     More...
Intercell AG Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection     More...
Curis, Inc. (CRIS) Announces GDC-0449 Phase II Ovarian Cancer Trial Design     More...
DURECT Corporation (DRRX) Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology     More...
NeuroDiscovery Ltd NSL-101 Demonstrates Effective Pain Relief in Phase IIa Trial     More...
TRANSGENE (TRGNY) and Roche (RHHBY) Modify Clinical Development Program     More...
Celsion Corporation (CLN) Release: ThermoDox(R) Liver Cancer Study Phase I Results to Be Presented at ILCA Conference 2008     More...
ALSERES Pharmaceuticals, Inc. (ALSE) Announces Preclinical Study Results Demonstrating that Rho Inhibitors Could Be Useful in Promoting Bone Healing     More...
Barr Pharmaceuticals, Inc. (BRL) Receives Approval for Generic Version of Razadyne(R) Tablets     More...
Repair Stem Cell Institute Says Stanford University's Stem Cell Study Confirms the Futility of Embryonics in Human Therapy     More...
The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research     More...
Monsanto Company (MON) and Evogene Ltd. Collaborate on Yield and Stress Research     More...
Retigabine Agreement Can Give Meda AB (SE:MEDAa) Significant Royalty Income     More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: Enrollment Complete in 15-Year Long-Term Follow-Up Study Evaluating Impact of AVONEX(R) in Patients with Relapsing Multiple Sclerosis     More...